Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYMBanks - Regional
+$0.15 today
- Market cap
- $12.16B
- Beta
- 0.76
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$2.54
Volume 5.80M
Average 4.76M
CHYM Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Chime Financial, Inc. Class A Common StockNASDAQ: CHYM
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of $7.56M rose 2.0% year over year, behind the +6.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 1.4% from the prior quarter. Over 3 fiscal years it compounded at +60.2% a year.
Context
- Depreciation & amortization amounted to 1.4% of revenue in FY2025, down 0.1 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +2.0% toward the trailing-twelve-month pace of +6.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 30M USD
- Year-over-year change
- +18.2%
- 3-year CAGR
- +60.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 30M | +18.2% |
| FY2024 | 2024-12-31 | 25.37M | +96.1% |
| FY2023 | 2023-12-31 | 12.94M | +77.2% |
| FY2022 | 2022-12-31 | 7.3M | — |
Depreciation & Amortization vs competitors
How CHYM compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +6.5% is the 5th highest of 7, against a peer median of +17.8%.
- Depreciation & amortization amounts to 1.3% of revenue for CHYM, versus a peer median of 3.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥26.14B JPY | +17.6% | +22.6% | 6.6% | |
| LTM Jun 2026 | $2.42B USD | +50.8% | -5.2% | 23.8% | |
| LTM Jun 2026 | $1.2B USD | +18.1% | +15.1% | 3.4% | |
| LTM Jun 2026 | $963M USD | -2.5% | -9.9% | 2.8% | |
| LTM Sep 2026 | $148.56M USD | +63.2% | +40.2% | 0.7% | |
| LTM Jun 2026 | $30.55M USD | +6.5% | +60.2% | 1.3% | |
| LTM Jun 2026 | $7.65M USD | +4.3% | -0.0% | 1.2% | |
| Peer median (excluding CHYM) | — | +17.8% | +7.5% | 3.1% | |
Competitors are the stored peer set for CHYM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.01B | 1.28B | 1.67B | 2.19B |
| Cost of Revenue | 214.69M | 219.74M | 207.51M | 309.03M |
| Gross Profit | 794.15M | 1.06B | 1.47B | 1.88B |
| Gross Margin | 78.7% | 82.8% | 87.6% | 85.9% |
| Research & Development | 242.43M | 259M | 309.58M | 934.93M |
| Selling, General & Admin | 603.94M | 598.75M | 696.99M | 1.15B |
| Operating Expenses | 1.27B | 1.29B | 1.53B | 2.92B |
| Depreciation & Amortization | 7.3M | 12.94M | 25.37M | 30M |
| EBITDA | (471.4M) | (222.85M) | (36.83M) | (979.11M) |
| EBITDA Margin | -46.7% | -17.4% | -2.2% | -44.8% |
| Operating Income | (478.7M) | (235.79M) | (62.2M) | (1.04B) |
| Operating Margin | -47.5% | -18.4% | -3.7% | -47.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 8.11M | 32.82M | 39.47M | 30.87M |
| Income Before Tax | (470.59M) | (202.97M) | (22.73M) | (1.01B) |
| Pre-Tax Margin | -46.6% | -15.9% | -1.4% | -46.1% |
| Income Tax Expense | (337K) | 234K | 2.61M | 831K |
| Net Income | (470.25M) | (203.2M) | (25.34M) | (1.01B) |
| Net Margin | -46.6% | -15.9% | -1.5% | -46.2% |
| EPS (Basic) | (1.29) | (0.56) | (0.07) | (2.67) |
| EPS (Diluted) | (1.29) | (0.56) | (0.07) | (2.60) |
| Weighted Avg Shares | 364.42M | 364.42M | 364.42M | 378.75M |
| Weighted Avg Shares (Diluted) | 364.42M | 364.42M | 364.42M | 388.17M |
Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYM
Intrinsic Alpha fair value
Locked
Current Price
$32.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.